Related Experiment Video

Updated: Jul 18, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Chronicles in drug discovery

Maria Angels Moral1, Valeria K Khurdayan, Jordi Bozzo

  • 1Prous Science Medical Information Department, Barcelona, Spain. journals@prous.com

Drug News & Perspectives
|December 13, 2006
PubMed

Insights

Chemoprevention strategies aim to reduce cancer risk using agents that halt carcinogenic processes. Several agents, including Bowman-Birk inhibitor concentrate, budesonide, NCX-4016, and statins, are in clinical trials for various cancers.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Prevention

Background:

  • Chemoprevention is a promising strategy to reduce cancer incidence and mortality.
  • Identifying safe and effective chemopreventive agents is a critical area of cancer research.
  • Carcinogenic processes can be targeted by specific agents to prevent cancer development.

Purpose of the Study:

  • To review the progress in the development of chemopreventive agents.
  • To highlight agents currently under clinical investigation for cancer prevention.
  • To discuss the potential of these agents in reducing the risk of specific cancers.

Main Methods:

  • Review of current clinical trial data and research findings.
  • Focus on agents with demonstrated potential in preclinical and clinical studies.
  • Analysis of chemopreventive strategies for various cancer types.

Main Results:

  • Bowman-Birk inhibitor concentrate is being investigated for head and neck cancers.
  • Budesonide shows potential as a chemopreventive agent for lung cancer.
  • NCX-4016 and statins are under investigation for colon and breast cancer prevention, respectively.

Conclusions:

  • Several agents are progressing through clinical trials for cancer chemoprevention.
  • These agents offer potential new strategies to reduce cancer risk.
  • Further research is essential to establish the safety and efficacy of these chemopreventive agents.

More Related Videos

In Vitro Transcription Assays and Their Application in Drug Discovery09:28

In Vitro Transcription Assays and Their Application in Drug Discovery

Published on: September 20, 2016

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...